Research Topics
Genomes and GenesSpecies | Julio PascualSummaryCountry: Spain Publications
| Collaborators
|
Detail Information
Publications
[Chronic migraine: treatment]Julio Pascual
Servicio de Neurologia, Hospital Universitario Central de Asturias, Oviedo, Asturias, Espana
Rev Neurol 54:S31-8. 2012....
Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacksA Oterino
Service of Neurology, University Hospital Marques de Valdecilla, Santander, Spain
J Headache Pain 12:235-8. 2011....
[Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients]J Pascual
Servicio de Neurologia, Hospital Universitario de Salamanca
Neurologia 21:188-91. 2006..To analyze our experience with the new, 5 mg intranasal formulation of zolmitriptan in the symptomatic treatment of migraine attacks...
[Experience with intranasal zolmitriptan in cluster headache]J Pascual
Servicio de Neurologia, Hospital Universitario Marques de Valdecilla, Santander
Neurologia 21:131-4. 2006..The objective is to analyse our experience with the new intranasal formulation of zolmitriptan 5 mg in the symptomatic treatment of cluster headache in daily clinical practice...
Value of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an exampleJulio Pascual
Service of Neurology, University Hospital, Salamanca 39008, Spain
J Headache Pain 7:27-33. 2006..In conclusion, PS studies augment our knowledge of antimigraine therapy, giving a more complete picture of how such agents work in the general population...
A woman with daily headachesJulio Pascual
Service of Neurology, University Hospital Marques de Valdecilla, Santander, Spain
J Headache Pain 6:91-2. 2005..This experience emphasises that a good clinical interview remains the most important point in the diagnosis and management of headache...
Primary cough headacheJulio Pascual
Service of Neurology, University Hospital Marques de Valdecilla, 39008 Santander, Spain
Curr Pain Headache Rep 9:272-6. 2005..These clinical characteristics allow its differential diagnosis from other entities, even though a craniocervical magnetic resonance imaging study is mandatory to rule out posterior fossa lesions, especially Chiari type-I malformation...
Efficacy and tolerability of almotriptan in postmarketing surveillance studiesJulio Pascual
Service of Neurology, University Hospital Marques de Valdecilla, Santander, Spain
Eur Neurol 53:34-40. 2005....
Testing the combination beta-blocker plus topiramate in refractory migraineJ Pascual
Service of Neurology, University Hospital, Salamanca, Spain
Acta Neurol Scand 115:81-3. 2007..To test treatment combining a beta-blocker plus topiramate in migraine patients previously resistant to the two medications in monotherapy...
[Spanish contribution to the clinical development of eletriptan: an analysis of controlled studies]J Pascual
Servicio de Neurologia, Hospital Universitario Marques de Valdecilla, Santander
Neurologia 19:414-9. 2004..Our aim has been to analyze the specific results from the Spanish participation in phase IIIa and IIIb clinical trials vs placebo and compare them with the results obtained in the global clinical development of eletriptan...
[Influence of botulinum toxin treatment on previous primary headaches in patients with cranio-cervical dystonia]J Pascual
Servicio de Neurologia, Hospital Universitario Marques de Valdecilla, Santander
Neurologia 19:260-3. 2004..Preliminary data suggest some beneficial effects of botulinum toxin type A (BT-A) on primary headaches...
How many migraine patients need prolonged (>1 year) preventive treatment? Experience with topiramateJ Pascual
Service of Neurology, University Hospital, Paseo de San Vicente 58 132, 37007, Salamanca, Spain
J Headache Pain 8:90-3. 2007..Our data suggest that the current practice recommending periods of preventive treatment of 3-6 months should be reconsidered for many patients...
Use of almotriptan in triptan-experienced and triptan-naïve patientsJulio Pascual
Service of Neurology, University Hospital, Salamanca, Spain
Curr Med Res Opin 23:2433-40. 2007..To evaluate the efficacy of oral almotriptan 12.5 mg as an acute treatment for migraine with a focus on triptan-experienced versus triptan-naïve patients...
Almotriptan: a review of 10 years' clinical experienceJulio Pascual
Hospital Universitario Central de Asturias, Oviedo, Spain
Expert Rev Neurother 10:1505-17. 2010..This suggests that almotriptan is an excellent choice for patients requiring specific acute migraine treatment...
[Chronic migraine as seen by neurologists and patients: results of the CIEN-mig project (III)]Julio Pascual
Servicios de Neurologia, Hospital Universitario Central de Asturias, Oviedo, Asturias
Rev Neurol 50:705-10. 2010..Data on the reality of chronic migraine in our clinics are scarce. AIM. To know the frequency of consultation and attitude of the neurologist regarding chronic migraine, and the opinion of patients with this condition...
[Satisfaction of the migraine patient attending neurology clinics: results of CIEN-mig project (II)]Julio Pascual
Servicios de Neurologia, Hospital Universitario Central de Asturias, 33006 Oviedo, Espana
Rev Neurol 50:641-5. 2010..Migraine is the most common neurological consultation in our country. AIM. To analyse the satisfaction level of the patient with migraine attending our clinics...
[Approach of neurologists in Spain to migraine: results of the CIEN-mig project (I)]Julio Pascual
Servicios de Neurologia, Hospital Universitario Central de Asturias, Oviedo, Espana
Rev Neurol 50:577-83. 2010..Headache is the most frequent neurological reason for consultation in our country...
[Zonisamide in the preventive treatment of refractory migraine]Julio Pascual-Gómez
Servicios de Neurologia, Hospital Universitario Marques de Valdecilla, Santander, Espana
Rev Neurol 50:129-32. 2010..Chronic migraine refractory to preventive treatment is a common clinical situation in general neurology clinics. The aim is to analyse our experience with zonisamide in the preventive treatment of patients with frequent refractory migraine...
[The role of the neuromodulators in the preventive treatment of migraine]J Pascual-Gómez
Servicio de Neurologia, Hospital Universitario Marques de Valdecilla, Cantabria, Espana
Rev Neurol 49:25-32. 2009..More than one quarter of patients who consult due to migraine need preventive treatment. At least half of these patients do not respond or cannot tolerate classical preventatives: beta-blockers, flunarizine or amitriptyline...
Other primary headachesJulio Pascual
Service of Neurology, University Hospital Marques de Valdecilla, 39008 Santander, Spain
Neurol Clin 27:557-71. 2009..Clinicians should be aware that these headaches may be symptomatic to structural lesions and therefore usually require careful neuroimaging evaluation...
[Preventive treatment of chronic migraine with zonisamide: a study in patients who are refractory or intolerant to topiramate]J Pascual-Gómez
Servicio de Neurologia, Hospital Universitario de Salamanca, Salamanca, Espana
Rev Neurol 47:449-51. 2008..About half of the patients with chronic migraine do not respond or do not tolerate the different migraine preventatives...
Almotriptan in triptan-naïve patients: new evidence of benefitsJ Pascual
University Hospital of Salamanca, Salamanca, Spain
Cephalalgia 28:14-20. 2008..These findings indicate that TN patients can expect excellent symptom control when they progress from non-specific analgesia to treatment with almotriptan and support the earlier use of triptans in line with the stratified care paradigm...
A review of rizatriptan, a quick and consistent 5-HT1B/1D agonist for the acute treatment of migraineJulio Pascual
Service of Neurology, University Hospital Marqués de Valdecilla UC, Spain
Expert Opin Pharmacother 5:669-77. 2004..The wafer formulation offers the convenience of being administered without water. As a result of its superior efficacy profile and generally good tolerability, rizatriptan can be considered as a first-line treatment for acute migraine...
[Almotriptan in the treatment of migraine attacks in clinical practice: results of the TEA 2000 observational study]J Pascual
Servicio de Neurologia, Hospital Universitario Marques de Valdecilla, Santander, Espana
Neurologia 18:7-17. 2003..Almotriptan, the most recent drug of the triptan family, has shown good efficacy and tolerability profile in clinical trials...
[Teaching needs of general practitioners in headaches]J Pascual
Centro Servicio de Neurología, Hospital Universitario Marques de Valdecilla, Santander, Espana
Neurologia 25:104-7. 2010..Headache in general, and migraine in particular, are the main reasons for general practitioners (GPs) to consult neurology services. Our aim was to analyse the current knowledge of GPs in migraine diagnosis...
Combined therapy for migraine prevention? Clinical experience with a beta-blocker plus sodium valproate in 52 resistant migraine patientsJ Pascual
Service of Neurology, Department of Medicine UC, University Hospital Marques de Valdecilla, Santander, Spain
Cephalalgia 23:961-2. 2003..Controlled trials are now necessary to determine the true advantage in efficacy of this combination in difficult to treat migraineurs...
Topiramate for patients with refractory migraine: an observational, multicenter study in SpainJ Pascual
University Hospital Marqués de Valdecilla UC, Santander
Neurologia 18:364-7. 2003..The efficacy of current preventive migraine treatments is limited. In addition, tolerability problems are not infrequent...
Pseudomigraine with lymphocytic pleocytosisJulio Pascual
Service of Neurology, University Hospital Marqués de Valdecilla UC, 39008 Santander, Spain
Curr Pain Headache Rep 7:224-8. 2003..This autoimmune attack may induce an aseptic leptomeningeal vasculitis, accounting for the headache and the transient symptoms likely through a spreading depression-like mechanism...
The relationship between homocysteine and genes of folate-related enzymes in migraine patientsAgustin Oterino
Department of Neurology, University Hospital Marques de Valdecilla, Santander, Cantabria, Spain
Headache 50:99-168. 2010..Genetic factors such as the MTHFR C677T polymorphism, and other polymorphisms in folate-related genes associated with high homocysteine levels, may contribute to increasing this vascular risk...
Multilocus analyses reveal involvement of the ESR1, ESR2, and FSHR genes in migraineAgustin Oterino
University Hospital Marqués de Valdecilla Neurology, Santander, Spain
Headache 48:1438-50. 2008..Research in this field has been controversial, especially in regard to ESR1 gene findings. None of the reports have yet to approach the problem from a multigenic point of view...
Association of migraine and ESR1 G325C polymorphismAgustin Oterino
Services of Neurology, Universitary Hospital Marques de Valdecilla, Santander, Spain
Neuroreport 17:61-4. 2006..Women carrying the C352C genotype were over 3 times more likely to suffer from migraine than those carrying the G325G genotype. Therefore, we conclude that ESR1 G325C polymorphism is associated with migraine in our population...
LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's diseaseJon Infante
Service of Neurology, University Hospital Marques de Valdecilla, University of Cantabria, 39008 Santander, Spain
Neurosci Lett 395:224-6. 2006..R1441G was not detected in any of our study subjects. The prevalence of G2019S mutation in unselected late-onset PD patients might be higher than previously reported: 3/16 (18.7%) of familial PD and 5/82 (6.1%) of sporadic PD...
Antiepileptic drugs for the treatment of chronic and episodic cluster headache: a reviewJulio Pascual
University Hospital, Salamanca, Spain
Headache 47:81-9. 2007....
Family-based association study of chromosome 6p12.2-p21.1 migraine locusAgustin Oterino
University Hospital Marqués de Valdecilla Neurology, Santander, Cantabria, Spain
Headache 52:393-9. 2012..2-21.1. This locus (named MIGR3) has not been replicated in the only genome-wide association scan study performed to date or in previous genome-wide linkage studies...
Genetic association study and meta-analysis of the HTR2C Cys23Ser polymorphism and migraineAgustin Oterino
Service of Neurology, University Hospital Marques de Valdecilla, E 39008, Santander, Spain
J Headache Pain 8:231-5. 2007..1; 99% CI=0.8-1.5, p=0.499). Our study did not confirm the HTR2C Cys23Ser polymorphism as a risk factor for migraine and MA...
Correlation between lipophilicity and triptan outcomesJulio Pascual
University Hospital M de Valdecilla, 39008 Santander, Spain
Headache 45:3-6. 2005..CONCLUSIONS: According to this analysis, a higher lipophilicity does not seem crucial to improve triptan efficacy. This physico-chemical property, however, correlates with higher CNS AE and, possibly, lower recurrence rates...
Lack of association of endothelial nitric oxide synthase polymorphisms and migraineMaria Toriello
Services of Neurology, University Hospital Marques de Valdecilla, Santander, Spain
Headache 48:1115-9. 2008..The aim of this study was to evaluate if 2 functional endothelial nitric oxide synthase (eNOS) gene polymorphisms might be risk factors for migraine...
Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerabilityJulio Pascual
University Hospital Neurology, Salamanca, Spain
Headache 47:1152-68. 2007..In the current literature, there is neither a reported systematic review comparing the efficacy of triptans at 30 minutes and 1 hour after the migraine treatment, nor data related to efficacy of new marketed triptans...
Bending the rule of monotherapy for migraine prevention?Randolph W Evans
Service of Neurology, University Hospital, Marques de Valdecilla, Santander 39008, Spain
Headache 45:748-50. 2005
Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preferenceJulio Pascual
Neurology Service, , Santander, Spain
Headache 45:1140-50. 2005..The results of this study, using patient-oriented, clinically relevant endpoints such as functional disability and preference, will help to guide practitioners in making recommendations for acute migraine treatment...
Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in SpainJulio Pascual
, Hospital Valdecilla, Santander, Spain
Headache 42:93-8. 2002..CONCLUSIONS: Rizatriptan was associated with significantly lower triptan tablet use and additional medication use per attack than the other triptans. Additional randomized studies are needed to confirm the conclusions of this study...
Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the betterJulio Pascual
Service of Neurology, , Santander, Spain
Headache 42:28-31. 2002..When used for mild intensity head pain, almotriptan 12.5 mg produced a significantly higher incidence of pain-free status at 1 and 2 hours and lower incidences of early headache recurrence or need for rescue medication...
Analysis of endothelial precursor cells in chronic migraine: A case-control studyAgustin Oterino
University Hospital Marques de Valdecilla, Spain
Cephalalgia 33:236-44. 2013..Conclusion: We observed higher number of activated EPCs in migraine patients than in controls. CD62E+ EPCs might be considered a marker for vascular damage in migraine patients...
Clinical benefits of early triptan therapy for migraineJulio Pascual
Department of Neurology, , Santander, Spain
Headache 42:10-7. 2002..In sum, early intervention with triptans can improve outcomes, avoiding much of the pain and disability associated with treating moderate or severe attacks...
Long-term evolution of chronic daily headache with medication overuse in the general populationNoelia Fontanillas
Health Center of Santoña, Cantabria, Spain
Headache 50:981-8. 2010..To investigate long-term efficiency of an intervention protocol for chronic daily headache with medication overuse (CDHwMO) in the general population...
Almotriptan: an effective and well-tolerated treatment for migraine painJulio Pascual
University Hospital Marques de Valdecilla, Santander, Spain
Drugs Today (Barc) 39:31-6. 2003..Almotriptan's high efficacy together with its excellent tolerability and safety profile confirm this new 5-HT(1B/1D) agonist as a drug of choice for the symptomatic treatment of migraine attacks...
Headaches precipitated by cough, prolonged exercise or sexual activity: a prospective etiological and clinical studyJulio Pascual
Service of Neurology, University Hospital of Salamanca, 37007, Salamanca, Spain
J Headache Pain 9:259-66. 2008....
[A triptan for every patient?]J Pascual Gomez
Servicio de Neurología Hospital Universitario Marqués de Valdecilla Santander Spain
Rev Clin Esp 203:545-7. 2003
Sarcoidosis presenting as transient ischemic attack statusIsabel González-Aramburu
Service of Neurology, University Hospital Marques de Valdecilla, Santander, Spain
J Stroke Cerebrovasc Dis 21:515-7. 2012..Sarcoidosis should be considered in the differential diagnosis of stroke of unknown origin in any young patient, even in the absence of other clinical or laboratory features of sarcoidosis...
Fusiform aneurysms of the vertebral artery: a hidden cause of exertional headache?Gerard Mauri
Neuroscience Area, University Hospital Central de Asturias, Oviedo, Spain
Cephalalgia 32:715-8. 2012..There is only one reported case of recurrent coital headache related to an unruptured saccular aneurysm of the carotid artery...
What differences exist in the appropriate treatment of congenital versus acquired adult Chiari type I malformation?César Ramón
Neuroscience Area, Service of Neurology, University Hospital Central de Asturias, Calle Celestino Villamil s n, Oviedo 33006, Spain
Curr Pain Headache Rep 15:157-63. 2011..CSF hypovolemia can be spontaneous or secondary to CSF removal. Treatment of acquired tonsillar herniation depends on the responsible etiology...
Experience with intravenous levetiracetam in status epilepticus: a retrospective case seriesGonzalo Gámez-Leyva
Service of Neurology, University Hospital, Salamanca, Spain
CNS Drugs 23:983-7. 2009..Status epilepticus is a medical emergency associated with significant morbidity and mortality...
Topiramate-responsive headache due to idiopathic intracranial hypertension in Behçet syndromeEnrique Palacio
Department of Neurology, University Hospital M de Valdecilla, Santander, Spain
Headache 44:436-7. 2004..Further studies are necessary, however, to confirm the significance of topiramate in this indication...
Thymidylate synthase promoter tandem repeat and MTHFD1 R653Q polymorphisms modulate the risk for migraine conferred by the MTHFR T677 alleleAgustin Oterino
Services of Neurology, University Hospital Marqués de Valdecilla UC, Santander 39008, Spain
Brain Res Mol Brain Res 139:163-8. 2005..08; 95% CI = 1.3-7.4). We conclude that the pathogenetic role of the MTHFR T677 allele in migraine is modulated by functional polymorphisms of TS and MTHFD1...
Primary cough headache, primary exertional headache, and primary headache associated with sexual activityJulio Pascual
Service of Neurology, University Hospital Central de Asturias, Oviedo, Spain
Handb Clin Neurol 97:459-68. 2010..Cough headache is a different condition when compared to headache due to physical exercise and sexual activity, which are clinical variants of the same entity...
An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patientsJ Pascual
Services of Neurology, University Hospital, Santander, Spain
Cephalalgia 21:680-4. 2001..5 mg were equivalent, which suggests that most migraine patients differentiate between triptans. A faster onset of action (speed of onset) was the most important reason for preference...
Almotriptan: pharmacological differences and clinical resultsJ Pascual
Service of Neurology, University Hospital Marques de Valdecilla, Santander, Spain
Curr Med Res Opin 17:s63-7. 2001..In summary, almotriptan's promising basic profile together with its excellent tolerability/safety profile and good efficacy confirm this new 5-HT(1B/D) agonist as a drug of choice for the symptomatic treatment of migraine attacks...
Is Chiari type I malformation a reason for chronic daily headacheCarmiña Riveira
Service of Neurology, University Hospital, Paseo de San Vicente 58 182, 37007 Salamanca, Spain
Curr Pain Headache Rep 11:53-5. 2007..Hydrocephalus and low intracranial pressure syndrome should be ruled out in patients showing tonsillar herniation in an MRI study and consulting due to daily headache...
Preventing disturbing migraine aura with lamotrigine: an open studyJulio Pascual
University Hospital M. de Valdecilla, Neurology, Santander, Cantabria, Spain
Headache 44:1024-8. 2004..CONCLUSIONS: Lamotrigine should be considered in clinical practice for the preventive treatment of selected patients with disturbing migraine auras. Lamotrigine seems worthy of a controlled trial as prophylaxis of migraine aura...
Smoking as a precipitating factor for migraine: a survey in medical studentsL López-Mesonero
Faculty of Medicine, University of Salamanca, Salamanca, Spain
J Headache Pain 10:101-3. 2009....
Quality of life in chronic daily headache: a study in a general populationVictoria Guitera
Service of Neurology, , Santander, Spain
Neurology 58:1062-5. 2002..CONCLUSIONS: In the general population, CDH reduced all QoL aspects studied with the SF-36. This reduction in QoL was most marked in subjects with analgesic overuse. QoL was affected more by the chronicity than by the intensity of pain...
Predictive model for the Migraine-ACT questionnaire in primary careJulio Pascual
Neurology Service, Hospital Universitario de Salamanca, Spain
Curr Med Res Opin 23:3033-9. 2007..Migraine is frequently under-treated. The 4-item Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire is a simple, patient-friendly tool to identify patients requiring change in acute migraine treatment...
Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron diseaseJon Infante
Service of Neurology, , Santander, Spain
Mov Disord 19:848-52. 2004..We conclude that motor neuron symptoms and signs may be a striking manifestation in SCA2, masking pre-existing cerebellar and extrapyramidal semeiology...
Permanent dysphasia after status epilepticus: long-term follow-up in an elderly patientJose L Fernandez-Torre
Department of Clinical Neurophysiology, University Hospital Marques de Valdecilla, Santander, Cantabria, Spain
Epilepsy Behav 8:677-80. 2006..Our case illustrates that permanent language dysfunction may occur after recurrent complex partial and secondarily generalized seizures...
Tolerability and efficacy of almotriptan in the long-term treatment of migraineJ Pascual
Servicio de Neurologia, University Hospital, Santander, Spain
Eur Neurol 45:206-13. 2001..Purpose: To assess the long-term tolerability and efficacy of oral almotriptan 12.5 mg administered for every migraine attack over a 1-year period...
Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraineJ Pascual
, Santander, Spain
Eur Neurol 45:275-83. 2001..001). Both active treatments were well tolerated. The most common side effects with rizatriptan and sumatriptan were nausea (6.6 and 6.9% of patients, respectively), dizziness (6.1 and 5.8%) and somnolence (7.4 and 6.7%)...
Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled studyJ Pascual
Servicio de Neurologia, University Hospital, Santander, Spain
Cephalalgia 20:588-96. 2000..Overall, the 12.5-mg dose was associated with the most favourable efficacy/tolerability ratio and is, therefore, the recommended dose...
[Determinants of prophylactic migraine therapy in Spain]J Pascual Gomez
Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Espana
Rev Neurol 45:513-8. 2007..Migraine interferes with the quality of life of patients. Prophylactic medication is an option to be considered in cases showing inefficiency of symptomatic medication or an increase in the number of attacks...
[Encephalitis due to antibodies against the NMDA receptor. A case report of a female patient with no associated tumour and a literature review]Sonia Herrero-Velázquez
Servicio de Neurologia, Hospital Clinico Universitario de Valladolid, 47005 Valladolid, Espana
Rev Neurol 50:661-6. 2010..We report on a new case and review the body of knowledge currently available on this recently identified condition...
Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case studyJose Berciano
Service of Neurology, University Hospital Marques de Valdecilla, University of Cantabria, Santander, Spain
Mov Disord 17:812-6. 2002..Putaminal preservation accounts for good response to both levodopa therapy and subthalamic nucleus stimulation...
Epilepsia partialis continua of the abdominal muscles: a detailed electrophysiological study of a caseJose L Fernandez-Torre
Department of Clinical Neurophysiology, Hospital Universitario Marques de Valdecilla, Santander, Spain
Mov Disord 19:1375-8. 2004....
Clinical experience with headaches in preadolescent childrenJ Pascual
Department of Medicine and Psychiatry, , Santander, Spain
Headache 35:551-3. 1995..Even though, in terms of frequency, headache is a very common reason for neurology consultation, the present results show that the majority of preadolescents consulting because of headache suffer from benign conditions...
Preventive effects of hyperbaric oxygen in cluster headacheJ Pascual
Service of Neurology, , Santander, Spain
Headache 35:260-1. 1995..Case 3 only improved in frequency, while the remaining patient showed no benefit. These findings suggest that daily hyperbaric oxygen treatment can be used as a transient preventive treatment for desperate cluster headache sufferers...
Kaplan Award 1998. Epidemiology of chronic daily headache in the general populationJ Castillo
Health Center of Camargo, Santander, Spain
Headache 39:190-6. 1999..The prevalence of chronic daily headache subtypes shown here differs from data obtained from headache clinics, emphasizing that caution is needed in extrapolating data from specialized units to the general population...
Coexistence of chronic paroxysmal hemicrania and benign cough headacheI Mateo
Department of Medicine and Psychiatry, Service of Neurology, , Santander, Spain
Headache 39:437-8. 1999..The possible pathophysiological significance of this concurrence of both types of indomethacin-responsive pain is discussed...
[Personality changes in chronic daily headache: a study in the general population]V Guitera
, , , Santander
Neurologia 16:11-6. 2001..This personality profile is still found more frequently in patients presenting symptomatic medication abuse...
Chronic daily headache with analgesic overuse: epidemiology and impact on quality of lifeR Colas
Health Center of Santoña, University Hospital Marqués de Valdecilla UC, Cantabria, Spain
Neurology 62:1338-42. 2004..To analyze the prevalence and demography of chronic daily headache (CDH) with analgesic overuse...
Serious migraine: a study of some epidemiological aspectsJ Pascual
Department of Medicine, , Santander, Spain
Headache 30:481-4. 1990..Our results may help in planning the public health aspect of migraine and add some light to the natural history of this common condition...
[New prospects in the treatment of migraine]J Pascual
Servicio de Neurologia, Hospital Universitario Marques de Valdecilla, Santander
Neurologia 14:26-35. 1999..From this review we conclude that while there have been relevant advances in the symptomatic treatment of migraine, there is a need for the development of better preventive compounds...
The distinctive headache of the occipital condyle syndrome: a report of four casesG Moris
Department of Medicine and Psychiatry, University Hospital Marques de Valdecilla, Santander, Spain
Headache 38:308-11. 1998..The occipital condyle syndrome may be the first manifestation of cancer or of chronic inflammatory lesions; recognition of this distinctive headache enables the clinical diagnosis to be made...
Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patientsE Quintela
Health Centre of Astillero, University Hospital, Salamanca, Spain
Cephalalgia 26:1051-60. 2006..In conclusion, around 80% of unselected migraineurs experience RS and PS. Migraine with aura and severe pain are risk factors for experiencing PS and RS, while preventatives were protective, especially for PS...
GNAS1 T393C polymorphism is associated with migraineA Oterino
Service of Neurology, University Hospital Marqués de Valdecilla UC, Santander, Spain
Cephalalgia 27:429-34. 2007..20; 95% CI 1.14-4.40; P=0.019) higher than TT/TC genotypes. In conclusion, the GNAS1 T393C variant is associated with migraine, which suggests a genetic basis for its higher SNS sensitivity...
Good news for chronic migraineJulio Pascual
J Headache Pain 7:169-71. 2006
More lessons for the treatment of chronic daily headacheJulio Pascual
J Headache Pain 9:3-4. 2008
Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparisonHans Christoph Diener
Department of Neurology, University of Essen, Essen, Germany
Eur Neurol 47:99-107. 2002..001) at 2 h. Adverse events were generally mild or moderate and transient. This randomised trial shows that oral eletriptan is more efficacious in the acute treatment of migraine than oral Cafergot and is well tolerated...
Everolimus in clinical practice--renal transplantationJulio Pascual
Servicio de Nefrologia, Hospital Ramon y Cajal, Carretera de Colmenar, Km9 100, 28034 Madrid, Spain
Nephrol Dial Transplant 21:iii18-23. 2006..In conclusion, everolimus may permit reduced exposure to CNIs in renal transplant recipients, with the potential to improve tolerability and renal function...
How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trialsCarl G H Dahlöf
Gothenburg Migraine Clinic, Sociala Huset, Sweden
Headache 42:99-113. 2002..In conclusion, almotriptan's consistent pharmacokinetics and good efficacy, in combination with excellent tolerability, make it an attractive choice in the acute treatment of migraine attacks...
Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trialsJulio Pascual
Servicio de Nefrología Hospital, Ramon y Cajal, Carretera de Colemenar km 9, 280034 Madrid, Spain
Transplantation 78:1548-56. 2004..A new examination of this topic including only randomized, controlled trials based on currently used, new, potent therapy with calcineurin inhibitors and mycophenolate mofetil (MMF), avoiding early trials with azathioprine, is justified...
Topiramate in the prophylactic treatment of cluster headacheMiguel J A Láinez
Department of Neurology, Hospital Clinico Universitario, Universidad de Valencia, Avenida Blasco Ibañez 17, 46 010 Valencia, Spain
Headache 43:784-9. 2003..The role of topiramate in the prophylactic treatment of cluster headache is still unclear. The aim of this study was to evaluate the effectiveness of topiramate in a group of patients with refractory episodic or chronic cluster headache...
Cough headache, indomethacin, and surgeryJulio Pascual
Headache 44:290. 2004
Concentration-controlled everolimus (Certican): combination with reduced dose calcineurin inhibitorsJulio Pascual
Servicio de Nefrologia, Hospital Ramon y Cajal, Madrid, Spain
Transplantation 79:S76-9. 2005..This suggests that concentration-controlled everolimus can be successfully combined with optimized administration of CsA and that this regimen may maximize immunosuppression, whilst preserving renal function...
Clinical experience with everolimus (Certican): optimizing dose and tolerabilityJulio Pascual
Servicio de Nefrologia, Hospital Ramon y Cajal, Madrid, Spain
Transplantation 79:S80-4. 2005..As a result of its mode of action, this class of agent (i.e., everolimus and sirolimus) is associated with certain adverse events (e.g., lymphocele, arthralgia, edema and hyperlipidemia)...
Everolimus therapeutic concentration range defined from a prospective trial with reduced-exposure cyclosporine in de novo kidney transplantationJohn M Kovarik
Novartis Pharmaceuticals, Basel, Switzerland and Rueil Malmaison, France
Ther Drug Monit 26:499-505. 2004..Maintaining everolimus troughs in the range 3 to 8 ng/mL in the first posttransplant year with reduced-exposure cyclosporine is associated with good efficacy and safety profiles...
Clinical experience with everolimus (Certican) in elderly recipients: the "old-for-old" conceptJulio Pascual
Servicio de Nefrologia, Hospital Ramon y Cajal, Madrid, Spain
Transplantation 79:S85-8. 2005....
Efficacy of therapeutic intervention in headache units in patients with frequent headaches: the EFUNCE studyMiguel J A Láinez
Department of Neurology, Hospital Clinico Universitario, University of Valencia, Spain
Headache 46:818-20. 2006..The results of the first 30 patients showed a significant improvement in different headache parameters and a high degree of satisfaction with the treatment received...
Conversion to everolimus in a patient with arterial hypertension and recurrent cutaneous neoplasia--a case reportJulio Pascual
Servicio de Nefrologia, Hospital Ramon y Cajal, Carretera de Colmenar, Km9 100, 28034 Madrid, Spain
Nephrol Dial Transplant 21:iii38-41. 2006..Therefore, conversion to everolimus from CsA in a renal transplant recipient led to improvements in blood pressure and resolution of recurrent cutaneous neoplasia, with no evidence of rejection or changes in renal function...
Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplantJulio Pascual
Servicio Nefrologia, Hospital Ramon y Cajal, Madrid, Spain
Transplantation 82:55-61. 2006..The challenge in renal transplantation is to improve long-term patient and graft survival without increasing early acute rejection by minimizing immunosuppression...
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trialYves Vanrenterghem
Department of Nephrology, University Hospital Gasthuisberg, Leuven, Belgium
Am J Transplant 5:87-95. 2005..A longer follow-up will be needed to confirm the expected advantages for the long-term outcome and to assess the long-term safety of this minimization of immunosuppressive therapy...
Ischemic heart disease after renal transplantation in patients on cyclosporine in SpainRoberto Marcen
Department of Nephrology, Ramon y Cajal, Madrid, Spain
J Am Soc Nephrol 17:S286-90. 2006..Emphasis should be placed on the need to stop smoking and to control hypertension and pre- and posttransplantation levels of serum cholesterol...
[Chiari type I malformation-related cephalea appearing at the time of blowing during alcohol controls]José Carlos Gómez-Sánchez
Med Clin (Barc) 130:557-8. 2008
